|  | 
| Mechanismfungal CYP51A1 inhibitors | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhaseDiscontinued | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
|  | 
|  | 
| Active Org.- | 
|  | 
| Active Indication- | 
|  | 
| Drug Highest PhasePending | 
| First Approval Ctry. / Loc.- | 
| First Approval Date- | 
100 Clinical Results associated with Actavis A/S
0  Patents (Medical) associated with Actavis A/S
100 Deals associated with Actavis A/S
100 Translational Medicine associated with Actavis A/S